From Mom to Baby: Antibodies and Infant Health

Susan Hepworth, Mitchell Goldstein, MD, MBA, CML

National Coalition for Infant Health logo

Everyone knows children inherit some things from their parents: their blue eyes, their curly hair, or perhaps their love of the outdoors. Moms take prenatal vitamins and get maternal vaccines like Tdap to transfer health benefits and good antibodies to their unborn babies. (1, 2)

However, some maternal antibodies carry risks that pregnant women should understand. Though serious dangers are rare, expectant mothers should be aware of them and prepared to discuss them with their doctors as part of their prenatal care.

[PICTURE OF PREGNANT MOTHER]

When Mom’s Immune System Fights Baby’s Blood Cells

When a baby’s blood type is incompatible with his or her mother’s, sometimes the mom’s immune system sends antibodies to “fight” the baby’s red blood cells. This rare condition, known as hemolytic disease of the fetus and newborn, affects between 3 and 80 pregnancies per 100,000, usually during the second or subsequent pregnancies. (3)

Severe symptoms, while extremely rare, once took the lives of thousands of infants every year. Medical progress has dramatically reduced that number. Hemolytic disease of the fetus and newborn is treatable today with fetal blood transfusions.

When Baby Inherits Incompatible Blood Cells from Dad

Another rare disease stemming from blood-cell incompatibility occurs when a baby inherits blood platelets from his or her father. When this happens, the mom’s immune system may respond to her baby’s unfamiliar platelets as if they were attacking her, sending harmful antibodies into the womb and giving the child fetal and neonatal alloimmune thrombocytopenia.

There is no national screening for either blood cell-type incompatibility condition or test to predict their severity. The most common indicator is a sibling who already has it. So doctors should closely monitor expectant mothers during subsequent pregnancies and prepare for delivery and neonatal care accordingly. (4, 5)

When Mom Has Certain Autoimmune Diseases

Sometimes harmful antibodies transferred to unborn babies have nothing to do with compatibility but result from their mothers’ immune systems. This situation is the case with congenital heart block. When a woman with an autoimmune condition like lupus or Sjogren’s syndrome gets pregnant, her body may create antibodies that attack her child’s heart as it develops in the womb. (6, 7)

Congenital heart block is very rare, affecting one in every 15,000-20,000 births. Thanks to ongoing advances in medical imaging technology, it is also becoming easier to diagnose. Current treatments include certain medications and the insertion of a pacemaker in the baby’s heart after the baby is born.

These conditions can happen, even if an expectant mom follows every prenatal protocol, which is why new, better and less invasive treatments are needed. The good news is that scientists are working to develop better tests and treatments – for all of these and other rare, fetal, and infant conditions.

Doctors know what to look for and test for these conditions as necessary. Women should know and ask about them to better advocate for themselves and their children.

References:

1. https://www.mayoclinic.org/healthy-lifestyle/pregnancy-week-by-week/in-depth/prenatal-vitamins/art-20046945

2. https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/tdap-vaccine-pregnancy.html

3. https://pubmed.ncbi.nlm.nih.gov/26637714/

4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651544/

5. https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.15642

6. https://www.mayoclinic.org/diseases-conditions/lupus/symptoms-causes/syc-20365789

7. https://www.mayoclinic.org/diseases-conditions/sjogrens-syndrome/symptoms-causes/syc-20353216

8. https://rarediseases.org/rare-diseases/heart-block-congenital/

Disclosure: No relevant disclosures noted

Corresponding Author
Susan Hepworth
Director
National Coalition for Infant Health

Susan Hepworth
Director
National Coalition for Infant Health 2020 K Street NW
Suite 505
Washington, DC 20006
Email: 
info@infanthealth.org

Dr. Mitch Goldstein, MD

Mitchell Goldstein, MD
Professor of Pediatrics
Loma Linda University School of Medicine
Division of Neonatology
Department of Pediatrics
mgoldstein@llu.edu